7.45 USD
↗ 1.11 (17.51%)AT CLOSE (11:59 AM EDT)
Eupraxia Pharmaceuticals Inc. Common Stock
EPRXNASDAQ • USD
7.60
↗ 0.15 (2.01%)
POST MARKET (AS OF 07:38 PM EDT)
Post Market
AS OF 07:38 PM EDT
7.60
↗ 0.15 (2.01%)
Market: OPEN
Shares of Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) are trading at $7.60. The technical outlook is "Buy" based on moving average alignment, RSI, and MACD signals. Key drivers include a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Sep 2, 2026.
Open?$6.40
High?$7.47
Low?$6.33
Prev. Close?$6.34
Volume?750.0K
Avg. Volume?N/A
VWAP?$7.09
Bid / Ask
Bid?$6.35 × 100
Ask?$8.60 × 100
Spread?$2.25
Midpoint?$7.48
Valuation & Ratios
Market Cap?418.9M
Shares Out?65.0M
Float?5.8M
Float %?85.0%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs. Currently, the company has two distinct clinical development programs, one targeting EoE and the second targeting chronic Osteoarthritis pain in the knee and has completed a Phase 2b clinical trial with EP-104IAR in knee OA.
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestSqueeze Risk
Short % of Float?109.97%Squeeze Risk
Short Interest?6.3M
Days to Cover?28.8
Free Float5.8M
Avg Daily Volume220.3K
Settlement Date2026-08-14